Perspective Therapeutics Inc CATX shares are trading lower by 12.9% to $0.38 Thursday morning after the company announced the pricing of an underwritten public offering.
The offering includes 132,075,218 shares of common stock at $0.37 per share and pre-funded warrants for 30,086,944 shares at $0.369 per warrant. The total gross proceeds are estimated to be around $60 million.
Oppenheimer & Co. and B. Riley Securities are serving as joint book-running managers, and there is an option for underwriters to purchase up to an additional 24,324,324 shares within 30 days.
See Also: Healthcare Insurance Giant Humana Stock Hits 52-Week Low
According to data from Benzinga Pro, CATX has a 52-week high of $0.73 and a 52-week low of $0.20.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
